FOXP3<sup>+ </sup>T<sub>regs </sub>and B7-H1<sup>+</sup>/PD-1<sup>+ </sup>T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy
<p>Abstract</p> <p>Background</p> <p>Recent studies have demonstrated a direct involvement of B7-H1, PD-1 and FOXP3 molecules in the immune escape of cancer. B7-H1 is an inhibitory molecule that binds to PD-1 on T lymphocytes, while FOXP3 is a marker for regulatory T ce...
Main Authors: | Al-Tweigeri Taher, Elkum Naser, Tulbah Asma, Barhoush Eman, Ghebeh Hazem, Dermime Said |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-02-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/8/57 |
Similar Items
-
Organomonophosphines in Pt(η<sup>3</sup>-X<sup>1</sup>X<sup>2</sup>X<sup>3</sup>)(PR<sub>3</sub>), (X = N<sup>1</sup>, N<sup>2</sup>, N<sup>3</sup>; S<sup>1</sup>, S<sup>2</sup>, S<sup>3</sup>; or Te<sup>1</sup>, Te<sup>2</sup>, Te<sup>3</sup>) Derivatives: Structural Aspects
by: Milan Melník, et al.
Published: (2023-06-01) -
Increased CD3<sup>+</sup>, CD8<sup>+</sup>, or FoxP3<sup>+</sup> T Lymphocyte Infiltrations Are Associated with the Pathogenesis of Colorectal Cancer but Not with the Overall Survival of Patients
by: Ana Margarida Barbosa, et al.
Published: (2021-08-01) -
Structural Aspects of Pt(η<sup>3</sup>–P<sup>1</sup>C<sub>2</sub>X<sup>1</sup>C<sub>2</sub>P<sup>2</sup>)(Y) Derivative Types
by: Milan Melník, et al.
Published: (2023-09-01) -
HETerogeneous vectorized or Parallel (HETPv1.0): an updated inorganic heterogeneous chemistry solver for the metastable-state NH<sub>4</sub><sup>+</sup>–Na<sup>+</sup>–Ca<sup>2+</sup>–K<sup>+</sup>–Mg<sup>2+</sup>–SO<sub>4</sub><sup>2−</sup>–NO<sub>3</sub><sup>−</sup>–Cl<sup>−</sup>–H<sub>2</sub>O system based on ISORROPIA II
by: S. J. Miller, et al.
Published: (2024-03-01) -
Heterotridentate Organomonophosphines in Pt(κ<sup>3</sup>–X<sup>1</sup>P<sup>1</sup>X<sup>2</sup>)(Y) (X<sup>1,2</sup> = N<sup>1,2</sup> or S<sup>1,2</sup>), Pt(κ<sup>3</sup>–P<sup>1</sup>N<sup>1</sup>X<sup>1</sup>)(Y) (X<sup>1</sup> = O, C, S or Se) Pt(κ<sup>3</sup>–P<sup>1</sup>S<sup>1</sup>Cl<sup>1</sup>)(Cl) and Pt(κ<sup>3</sup>–P<sup>1</sup>Si<sup>1</sup>N<sup>1</sup>)(OL)—Structural Aspects
by: Milan Melník, et al.
Published: (2022-12-01)